Drawing for THE FINNOTYPE COMPANY

USPTO serial 79027924

THE FINNOTYPE COMPANY

Reviewed by CopyMark Law Group

Reg. 3409298Status 404
Filing date
Status date
Registration date
Apr 8, 2008
Examiner
AMOS, TANYA L
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE FINNOTYPE COMPANY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James M. Slattery

James M. Slattery Birch, Stewart, Kolasch & Birch, LLPP.O. Box 747Falls Church, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical research, pharmaceutical research and development services in the field of molecular medicine, namely, clinical studies and health care; medical and scientific research, namely, conducting clinical trials featuring the recruitment of study subjects into clinical trials and scientific research consulting for improved clinical trial design; pharmaceutical research in the field of molecular medicine featuring modelling of clinical trials; medical research that analyzes data to identify patterns across patient groups or disease progression; disease management studies, namely, conducting clinical and observational trials to improve disease management; scientific research consulting for improved disease management through clinical and observational trials; scientific research consultancy of health outcomes featuring pharmaco-economic analyses; medical research featuring the identification of disease related biomarkers, the identification and validation of disease characteristics in specific gene biomarkers, protein biomarkers and metabolite biomarkers for use in drug development, molecular diagnostics and improved patient care; licensing of diagnostic methods using identification of disease related biomarkers; medical research featuring the discovery and validation of biomarkers for the association with disease phenotype, namely, validating the clinical relevance of biomarkers and characterizing new biomarkersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 1, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 1, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 11, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 24, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 24, 2015INPCINVALIDATION PROCESSED—
Jul 26, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 26, 2014C71TCANCELLED SECTION 71—
Dec 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 25, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 25, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 8, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 8, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 27, 2008OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 13, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 13, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 22, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2008NPUBNOTICE OF PUBLICATION—
Dec 18, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 9, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 17, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 26, 2007ALIEASSIGNED TO LIE—
Sep 20, 2007MAILPAPER RECEIVED—
May 28, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 28, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 24, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 23, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 23, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 10, 2006RFNTREFUSAL PROCESSED BY IB—
Oct 23, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 23, 2006RFRRREFUSAL PROCESSED BY MPU—
Oct 19, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 18, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 13, 2006DOCKASSIGNED TO EXAMINER—
Oct 13, 2006NWAPNEW APPLICATION ENTERED—
Oct 12, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance